Search results for "Highlights"

Results 41 - 50 of about 418 for "Highlights".
Sort by: Relevance | Newest | Oldest

Avoiding hypoglycemia most compelling reason for deintensifying diabetes meds

Researchers presented older adults with type 2 diabetes with three scenarios in which deintensification may be indicated—poor health, limited life expectancy, and high hypoglycemia risk—and found that 8%, 4%, and 75%, respectively, viewed deintensification positively.
14 Oct 2022

Newer oral diabetes meds could provide significant benefits in type 1 diabetes

A retrospective chart review found that glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors were associated with benefits including weight loss and reduced use of insulin in patients with type 1 diabetes.
11 Nov 2022

Initiation of glucose-lowering therapies may be associated with reduced physical activity

An analysis of 148 participants from three randomized trials found that starting liraglutide, empagliflozin, or sitagliptin was associated with reduction in physical activity of about 1,000 steps per day or 10 minutes of moderate to vigorous physical activity per day.
16 Sep 2022

Patients diagnosed by OGTT without elevated HbA1c had similar CV, renal disease risks as those without diabetes

A prospective U.K. study found that patients with diabetes based on an oral glucose tolerance test (OGTT) often did not have a diabetic HbA1c level, and risks of cardiovascular (CV) and kidney disease in these patients were similar to those in the nondiabetic general population.
16 Sep 2022

Comprehensive telehealth approach improved HbA1c in type 2 diabetes

Compared with a simpler approach of telemonitoring and care coordination, an intervention that added self-management and diet/activity support, medication management, and depression care improved outcomes in veterans with poorly controlled type 2 diabetes, a trial found.
12 Aug 2022

Review finds blood pressure-lowering effects weaker in patients with type 2 diabetes

Absolute risk reductions did not differ substantially between people with and without type 2 diabetes because of the higher absolute cardiovascular risk among those with the condition, according to a new meta-analysis.
12 Aug 2022

Glucose-lowering treatment after type 2 diabetes diagnosis differed by race/ethnicity

Among 77,199 patients in a U.S. health system with a new diagnosis of diabetes from 2005 to 2016, 47% started a diabetes medication within 12 months. Prevalence differed by race and ethnicity, although the difference was mitigated by variation in HbA1c levels.
12 Aug 2022

Spotlight on inpatient hyperglycemia

A new guideline offered recommendations on managing hyperglycemia in hospital patients with or without diabetes. Recent studies looked at the effects of elevated blood glucose levels after surgery and in the ICU.
8 Jul 2022

Dietary protein sources associated with type 2 diabetes risk, study finds

Data from the Women's Health Initiative indicated that when 5% of energy intake from plant protein was substituted for animal protein, type 2 diabetes risk was estimated to decrease by approximately 21%.
8 Jul 2022

Disparities by race, hospital type exist in diabetes-related lower-extremity amputations

The authors of a recent study called for public awareness, screening, and accessible and early multidisciplinary care, as well as neighborhood-level public health interventions, to reduce the disproportionate burden of lower-extremity amputation in underserved communities.
8 Jul 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next